Showing results (241-250 of 1,150) with videos related to
Sort By:
Pageof 115
Hepato-Gastroenterology|March 28, 2001
Nonpercutaneous therapies of hepatocellular carcinomaM ColomboJournal of Thrombosis and Haemostasis : JTH|January 25, 2011
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)A Gringeri, B Lundin, S von Mackensen, et al.Thrombosis and Haemostasis|March 4, 1991
Adverse effects of treatment with porcine factor VIIIA Gringeri, E Santagostino, F Tradati, et al.Blood|January 1, 1992
Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarctionA B Federici, S D Berkowitz, T S Zimmerman, et al.Blood|April 1, 1988
Isolation of an abnormal protein C molecule from the plasma of a patient with thrombotic diathesisE M Faioni, C T Esmon, N L Esmon, et al.Thrombosis and Haemostasis|September 24, 1999
High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuriaR A Ariëns, M Moia, E Rivolta, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1994
High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosisC R Falcon, M Cattaneo, D Panzeri, et al.Blood|November 1, 1989
DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factorM Cattaneo, M Moia, P Delle Valle, et al.Thrombosis Research|February 15, 1986
Homozygous protein C deficiency with moderately severe clinical symptomsC Sharon, M C Tirindelli, P M Mannucci, et al.Obstetrics and Gynecology|August 1, 1986
Pregnancy in women with different types of von Willebrand diseaseM Conti, D Mari, E Conti, et al.Pageof 115